Evidence map›Paper›PMID 41125366›Full record

ArticleBMJ open quality2025

Adherence to a care pathway for inflammatory bowel disease in the southwest region of the Netherlands: results of a mixed-methods implementation study.

Elyke Hinke Visser, Sanne Allers, Reinier C A van Linschoten, Alexander G L Bodelier, Claire Fitzpatrick, Vincent de Jonge, Hestia Vermeulen, Evelyne Verweij, Sanne K van der Wiel, Daniëlle van der Horst and 3 more

Abstract read
In one paragraph

Article in BMJ open quality, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Elyke Hinke VisserDepartment of Gastroenterology & Hepatology, Franciscus Hospital, Rotterdam, Zuid-Holland, The Netherlands e.h.visser@erasmusmc.nl.ORCID 0000-0002-6259-4954
Sanne AllersDepartment of Health Policy & Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Reinier C A van LinschotenDepartment of General Practice, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands.
Alexander G L BodelierDepartment of Gastroenterology & Hepatology, Amphia Hospital, Breda, The Netherlands.
Claire FitzpatrickDepartment of Gastroenterology & Hepatology, IJsselland Hospital, Capelle aan den IJssel, The Netherlands.
Vincent de JongeDepartment of Gastroenterology & Hepatology, Albert Schweitzer Hospital, Dordrecht, The Netherlands.
Hestia VermeulenDepartment of Gastroenterology & Hepatology, Ikazia Hospital, Rotterdam, The Netherlands.
Evelyne VerweijDepartment of Gastroenterology & Hepatology, Maasstad Hospital, Rotterdam, The Netherlands.
Sanne K van der WielDepartment of Gastroenterology & Hepatology, Reinier de Graaf Gasthuis, Delft, The Netherlands.
Daniëlle van der HorstCrohn & Colitis NL, Woerden, The Netherlands.
Christine Janneke van der WoudeDepartment of Gastroenterology & Hepatology, Erasmus MC, Rotterdam, Zuid-Holland, The Netherlands.
Desiree van NoordDepartment of Gastroenterology & Hepatology, Franciscus Hospital, Rotterdam, Zuid-Holland, The Netherlands.
Rachel Louise WestDepartment of Gastroenterology & Hepatology, Franciscus Hospital, Rotterdam, Zuid-Holland, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn southwest Netherlands, hospitals collaborate to provide high-quality care for inflammatory bowel disease (IBD). To achieve this, a care pathway (CP) was implemented for treating IBD with advanced therapies. This study assessed the adherence to the CP and identified implementation barriers and facilitators.

methodsA mixed-methods study was conducted. Quantitative data collected from health records from December 2020 to March 2023 were used to evaluate adherence, and differences were analysed with generalised mixed models. Surveys and semistructured interviews with healthcare providers (HCPs) were used to identify barriers and facilitators, using the extended normalisation theory.

resultsThe study included 299 patients. Documentation of repeated screening for infectious diseases when prior tests exceeded 1 year decreased (p<0.001). Adherence to ordering blood tests as advised increased (p<0.001). For patients experiencing a flare, a small but significant increase was observed in the use of validated questionnaires for scoring disease activity (p=0.004). Adherence improved in registering smoking status (p=0.003), side effects (p<0.001), medication adherence (p<0.001) and ordering advised blood tests as recommended (p<0.001). Weight registration decreased (p=0.002).From 85 surveys, 42 were completed, with 11 interviews conducted. Facilitators were improving collaboration and the potential to standardise care. Barriers were the complexity of the implementation in health records, the difficulty for providers to change routines and IBD heterogeneity.

conclusionsAdherence to the CP appears to be challenging, due to the difficulty HCPs experience in changing routines. Discrepancies between performed and documented tasks may affect adherence rates. The gradual improvement suggests increased familiarity with the CP may enhance adoption.

trial registrationMEC-2020-075.

Indexed as

Critical PathwaysGuideline AdherenceInflammatory Bowel DiseasesAdultFemaleHumansMaleMiddle AgedNetherlandsSurveys and QuestionnairesChronic disease managementClinical practice guidelinesComplianceImplementation scienceQuality improvement

Identifiers

PMID41125366
PMCPMC12548584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.